Long-Term Outcomes of Two Different Initial Dosing Regimens of Intravitreal Ranibizumab Used to Treat Myopic Choroidal Neovascularization

  1. Calvo-González, C.
  2. Reche-Frutos, J.
  3. Fernández-Vigo, J.I.
  4. Sáenz-Francés, F.
  5. Fernández-Pérez, C.
  6. García-Feijóo, J.
Journal:
Ophthalmologica

ISSN: 1423-0267,  0030-3755

Year of publication: 2017

Volume: 238

Issue: 4

Pages: 196-204

Type: Article

DOI: 10.1159/000478030 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus